Skip to main navigation Skip to search Skip to main content

Hypogonadism in women with prader-willi syndrome— clinical recommendations based on a dutch cohort study, review of the literature and an international expert panel discussion

*Corresponding author for this work
  • Assistance publique – Hôpitaux de Paris
  • International Network for Research, Management and Education on Adults with PWS
  • European Reference Network on Rare Endocrine Conditions (ENDO-ERN)
  • Hammersmith Hospital
  • Karolinska Institutet
  • Karolinska University Hospital
  • Royal Prince Alfred Hospital
  • The University of Sydney
  • IRCCS Istituto Auxologico Italiano - Milano
  • IRCCS Ospedale pediatrico Bambino Gesù - Roma
  • Autonomous University of Barcelona
  • The Israel Multidisciplinary Prader-Willi Syndrome Clinic
  • Shaare Zedek Medical Center
  • Hebrew University School of Medicine
  • University of Kansas Medical Centre
  • University of Florida College of Medicine
  • Dutch Center of Reference for Prader-Willi Syndrome

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)
214 Downloads (Pure)

Abstract

Prader-Willi syndrome (PWS) is a rare neuroendocrine genetic syndrome. Characteristics of PWS include hyperphagia, hypotonia, and intellectual disability. Pituitary hormone deficiencies, caused by hypothalamic dysfunction, are common and hypogonadism is the most prevalent. Untreated hypogonadism can cause osteoporosis, which is already an important issue in PWS. Therefore, timely detection and treatment of hypogonadism is crucial. To increase understanding and prevent undertreatment, we (1) performed a cohort study in the Dutch PWS population, (2) thoroughly reviewed the literature on female hypogonadism in PWS and (3) provide clinical recommendations on behalf of an international expert panel. For the cohort study, we retrospectively collected results of a systematic health screening in 64 female adults with PWS, which included a medical questionnaire, medical file search, medical interview, physical examination and biochemical measurements. Our data show that hypogonadism is frequent in females with PWS (94%), but is often undiagnosed and untreated. This could be related to unfamiliarity with the syndrome, fear of behavioral changes, hygienic concerns, or drug interactions. To prevent underdiagnosis and undertreatment, we provide practical recommendations for the screening and treatment of hypogonadism in females with PWS.

Original languageEnglish
Article number5781
JournalJournal of Clinical Medicine
Volume10
Issue number24
DOIs
Publication statusPublished - 10 Dec 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Fingerprint

Dive into the research topics of 'Hypogonadism in women with prader-willi syndrome— clinical recommendations based on a dutch cohort study, review of the literature and an international expert panel discussion'. Together they form a unique fingerprint.

Cite this